Correction to: HCV immunodominant peptide mapping reveals unique HLA‑A* 02‑restricted signatures: insights for CD8⁺ T‑cell‑based vaccines and immunotherapies.

IF 2.9 4区医学 Q2 GENETICS & HEREDITY

Immunogenetics Pub Date : 2025-04-23 DOI:10.1007/s00251-025-01377-9

Laura Cardoso Corrêa-Dias, Ágata Lopes-Ribeiro, Geovane Marques-Ferreira, Letícia Gomes-de-Pontes, Thaiza Aline Pereira-Santos, Erik Vinicius de Sousa Reis, Thaís de Fátima Silva Moraes, Olindo Assis Martins-Filho, Edel Figueiredo Barbosa-Stancioli, Flávio Guimarães da Fonseca, Jordana Grazziela Coelho-Dos-Reis

引用次数: 0

查看原文本刊更多论文

修正：HCV免疫优势肽图谱揭示了独特的HLA - A* 02限制性特征：CD8+ T细胞疫苗和免疫疗法的见解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Immunogenetics 医学-免疫学

CiteScore

6.20

自引率

6.20%

发文量

审稿时长

1 months

期刊介绍： Immunogenetics publishes original papers, brief communications, and reviews on research in the following areas: genetics and evolution of the immune system; genetic control of immune response and disease susceptibility; bioinformatics of the immune system; structure of immunologically important molecules; and immunogenetics of reproductive biology, tissue differentiation, and development.

Correction to: HCV immunodominant peptide mapping reveals unique HLA‑A* 02‑restricted signatures: insights for CD8+ T‑cell‑based vaccines and immunotherapies.

Correction to: HCV immunodominant peptide mapping reveals unique HLA‑A* 02‑restricted signatures: insights for CD8⁺ T‑cell‑based vaccines and immunotherapies.